Clinical trial
Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
NCT05279768 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- January 20, 2025
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.